{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T01:04:32Z","timestamp":1793927072555,"version":"4.8.0"},"reference-count":84,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004281","name":"Narodowe Centrum Nauki","doi-asserted-by":"publisher","award":["Narodowe Centrum Nauki"],"award-info":[{"award-number":["Narodowe Centrum Nauki"]}],"id":[{"id":"10.13039\/501100004281","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biosci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Huntington\u2019s disease (HD) is a neurodegenerative disorder caused by the expansion of CAG repeats in the\n                      <jats:italic>HTT<\/jats:italic>\n                      gene, which results in a long polyglutamine tract in the huntingtin protein (HTT). One of the earliest key molecular mechanisms underlying HD pathogenesis is transcriptional dysregulation, which is already present in the developing brain. In this study, we searched for networks of deregulated RNAs crucial for initial transcriptional changes in HD- and HTT-deficient neuronal cells.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      RNA-seq (including small RNAs) was used to analyze a set of isogenic human neural stem cells. The results were validated using additional methods, rescue experiments, and in the medium spiny neuron-like cells. We observed numerous changes in gene expression and substantial dysregulation of miRNA expression in HD and\n                      <jats:italic>HTT<\/jats:italic>\n                      -knockout (\n                      <jats:italic>HTT<\/jats:italic>\n                      -KO) cell lines. The overlapping set of genes upregulated in both HD and\n                      <jats:italic>HTT<\/jats:italic>\n                      -KO cells was enriched in genes associated with DNA binding and the regulation of transcription. We observed substantial upregulation of the following transcription factors:\n                      <jats:italic>TWIST1<\/jats:italic>\n                      ,\n                      <jats:italic>SIX1<\/jats:italic>\n                      ,\n                      <jats:italic>TBX1<\/jats:italic>\n                      ,\n                      <jats:italic>TBX15<\/jats:italic>\n                      ,\n                      <jats:italic>MSX2<\/jats:italic>\n                      ,\n                      <jats:italic>MEOX2<\/jats:italic>\n                      and\n                      <jats:italic>FOXD1<\/jats:italic>\n                      . Moreover, we identified miRNAs that were consistently deregulated in HD and\n                      <jats:italic>HTT<\/jats:italic>\n                      -KO cells, including miR-214, miR-199, and miR-9. These miRNAs may function in the network that regulates\n                      <jats:italic>TWIST1<\/jats:italic>\n                      and\n                      <jats:italic>HTT<\/jats:italic>\n                      expression\n                      <jats:italic>via<\/jats:italic>\n                      a regulatory feed-forward loop in HD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      On the basis of overlapping changes in the mRNA and miRNA profiles of HD and\n                      <jats:italic>HTT<\/jats:italic>\n                      -KO cell lines, we propose that transcriptional deregulation in HD at early neuronal stages is largely caused by a deficiency of properly functioning HTT rather than a typical gain-of-function mechanism.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13578-025-01443-5","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:37:56Z","timestamp":1752136676000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["HTT loss-of-function contributes to RNA deregulation in developing Huntington\u2019s disease neurons"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4742-5001","authenticated-orcid":false,"given":"Emilia","family":"Koz\u0142owska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2586-0907","authenticated-orcid":false,"given":"Agata","family":"Cio\u0142ak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8233-1473","authenticated-orcid":false,"given":"Gra\u017cyna","family":"Adamek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Szcze\u015bniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7829-1926","authenticated-orcid":false,"given":"Agnieszka","family":"Fiszer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"1443_CR1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"The Huntington\u2019s Disease Collaborative Research Group","year":"1993","unstructured":"The Huntington\u2019s Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on huntington\u2019s disease chromosomes. Cell. 1993;72:971\u201383.","journal-title":"Cell"},{"key":"1443_CR2","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/B978-0-444-63233-3.00017-8","volume":"147","author":"R Ghosh","year":"2018","unstructured":"Ghosh R, Tabrizi SJ. Huntington disease. Handb Clin Neurol. 2018;147:255\u201378.","journal-title":"Handb Clin Neurol"},{"key":"1443_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-020-0389-4","author":"SJ Tabrizi","year":"2020","unstructured":"Tabrizi SJ, Flower MD, Ross CA, Wild EJ. Huntington disease: new insights into molecular pathogenesis and therapeutic opportunities. Nat Rev Neurol. 2020. https:\/\/doi.org\/10.1038\/s41582-020-0389-4.","journal-title":"Nat Rev Neurol"},{"key":"1443_CR4","doi-asserted-by":"publisher","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates GP, Dorsey R, Gusella JF, Hayden MR, Kay C, Leavitt BR, et al. Huntington disease. Nat Rev Dis Prim. 2015;1:15005.","journal-title":"Nat Rev Dis Prim"},{"issue":"JAN","key":"1443_CR5","first-page":"174074","volume":"9","author":"E Kerschbamer","year":"2016","unstructured":"Kerschbamer E, Biagioli M. Huntington\u2019s disease as neurodevelopmental disorder: altered chromatin regulation, coding, and non-coding RNA transcription. Front Neurosci. 2016;9(JAN):174074.","journal-title":"Front Neurosci"},{"key":"1443_CR6","doi-asserted-by":"crossref","unstructured":"Wiatr K, Szlachcic WJ, Trzeciak M, Figlerowicz M, Figiel M. Huntington disease as a neurodevelopmental disorder and early signs of the disease in stem cells. Mol Neurobiol. 2017;:1\u201321.","DOI":"10.1007\/s12035-017-0477-7"},{"key":"1443_CR7","doi-asserted-by":"publisher","first-page":"E762","DOI":"10.1073\/pnas.1715865115","volume":"115","author":"P Conforti","year":"2018","unstructured":"Conforti P, Besusso D, Bocchi VD, Faedo A, Cesana E, Rossetti G, et al. Faulty neuronal determination and cell polarization are reverted by modulating HD early phenotypes. Proc Natl Acad Sci. 2018;115:E762\u201371.","journal-title":"Proc Natl Acad Sci"},{"key":"1443_CR8","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1126\/science.aax3338","volume":"369","author":"M Barnat","year":"2020","unstructured":"Barnat M, Capizzi M, Aparicio E, Boluda S, Wennagel D, Kacher R, et al. Huntington\u2019s disease alters human neurodevelopment. Science. 2020;369:787\u201393.","journal-title":"Science"},{"key":"1443_CR9","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nn.4532","volume":"20","author":"The HD iPSC Consortium","year":"2017","unstructured":"The HD iPSC Consortium. Developmental alterations in huntington\u2019s disease neural cells and Pharmacological rescue in cells and mice. Nat Neurosci. 2017;20:648\u201360.","journal-title":"Nat Neurosci"},{"key":"1443_CR10","doi-asserted-by":"publisher","first-page":"E8765","DOI":"10.1073\/pnas.1807962115","volume":"115","author":"FA Siebzehnr\u00fcbl","year":"2018","unstructured":"Siebzehnr\u00fcbl FA, Raber KA, Urbach YK, Schulze-Krebs A, Canneva F, Moceri S, et al. Early postnatal behavioral, cellular, and molecular changes in models of huntington disease are reversible by HDAC Inhibition. Proc Natl Acad Sci U S A. 2018;115:E8765\u201374.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1443_CR11","doi-asserted-by":"publisher","first-page":"AUGUST","DOI":"10.7554\/eLife.17056","volume":"5","author":"L Li","year":"2016","unstructured":"Li L, Liu H, Dong P, Li D, Legant WR, Grimm JB, et al. Real-time imaging of Huntingtin aggregates diverting target search and gene transcription. Elife. 2016;5:AUGUST.","journal-title":"Elife"},{"key":"1443_CR12","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","volume":"277","author":"M DiFiglia","year":"1997","unstructured":"DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, et al. Aggregation of Huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Sci (80-). 1997;277:1990\u20133.","journal-title":"Sci (80-)"},{"key":"1443_CR13","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1111\/jnc.14853","volume":"151","author":"EE Wanker","year":"2019","unstructured":"Wanker EE, Ast A, Schindler F, Trepte P, Schnoegl S. The pathobiology of perturbed mutant Huntingtin protein-protein interactions in huntington\u2019s disease. J Neurochem. 2019;151:507\u201319.","journal-title":"J Neurochem"},{"key":"1443_CR14","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/S0166-2236(00)01721-5","volume":"24","author":"E Cattaneo","year":"2001","unstructured":"Cattaneo E, Rigamonti D, Goffredo D, Zuccato C, Squitieri F, Sipione S. Loss of normal Huntingtin function: new developments in huntington\u2019s disease research. Trends Neurosci. 2001;24:182\u20138.","journal-title":"Trends Neurosci"},{"key":"1443_CR15","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1523\/JNEUROSCI.2443-18.2018","volume":"39","author":"MF Mehler","year":"2019","unstructured":"Mehler MF, Petronglo JR, Arteaga-Bracho EE, Gulinello ME, Winchester ML, Pichamoorthy N, et al. Loss-of-huntingtin in medial and lateral ganglionic lineages differentially disrupts regional interneuron and projection neuron subtypes and promotes huntington\u2019s disease-associated behavioral, cellular and pathological hallmarks. J Neurosci. 2019;39:2443\u201318.","journal-title":"J Neurosci"},{"key":"1443_CR16","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.neuron.2016.02.003","volume":"89","author":"F Saudou","year":"2016","unstructured":"Saudou F, Humbert S. The biology of Huntingtin. Neuron. 2016;89:910\u201326.","journal-title":"Neuron"},{"key":"1443_CR17","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/81593","volume":"26","author":"I Dragatsis","year":"2000","unstructured":"Dragatsis I, Levine MS, Zeitlin S. Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice. Nat Genet. 2000;26:300\u20136.","journal-title":"Nat Genet"},{"key":"1443_CR18","doi-asserted-by":"publisher","first-page":"e1006846","DOI":"10.1371\/journal.pgen.1006846","volume":"13","author":"P Dietrich","year":"2017","unstructured":"Dietrich P, Johnson IM, Alli S, Dragatsis I. Elimination of Huntingtin in the adult mouse leads to progressive behavioral deficits, bilateral thalamic calcification, and altered brain iron homeostasis. PLOS Genet. 2017;13:e1006846.","journal-title":"PLOS Genet"},{"key":"1443_CR19","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/0092-8674(95)90542-1","volume":"81","author":"J Nasir","year":"1995","unstructured":"Nasir J, Floresco SB, O\u2019Kusky JR, Diewert VM, Richman JM, Zeisler J, et al. Targeted disruption of the huntington\u2019s disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell. 1995;81:811\u201323.","journal-title":"Cell"},{"key":"1443_CR20","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1126\/science.7618107","volume":"269","author":"MP Duyao","year":"1995","unstructured":"Duyao MP, Auerbach AB, Ryan A, Persichetti F, Barnes GT, McNeil SM, et al. Inactivation of the mouse huntington\u2019s disease gene homolog Hdh. Science. 1995;269:407\u201310.","journal-title":"Science"},{"key":"1443_CR21","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/ng1297-404","volume":"17","author":"JK White","year":"1997","unstructured":"White JK, Auerbach W, Duyao MP, Vonsattel JP, Gusella JF, Joyner AL, et al. Huntingtin is required for neurogenesis and is not impaired by the huntington\u2019s disease CAG expansion. Nat Genet. 1997;17:404\u201310.","journal-title":"Nat Genet"},{"key":"1443_CR22","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.nbd.2016.09.006","volume":"96","author":"EE Arteaga-Bracho","year":"2016","unstructured":"Arteaga-Bracho EE, Gulinello M, Winchester ML, Pichamoorthy N, Petronglo JR, Zambrano AD, et al. Postnatal and adult consequences of loss of Huntingtin during development: implications for huntington\u2019s disease. Neurobiol Dis. 2016;96:144\u201355.","journal-title":"Neurobiol Dis"},{"key":"1443_CR23","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1093\/hmg\/10.22.2515","volume":"10","author":"W Auerbach","year":"2001","unstructured":"Auerbach W, Hurlbert MS, Hilditch-Maguire P, Wadghiri YZ, Wheeler VC, Cohen SI, et al. The HD mutation causes progressive lethal neurological disease in mice expressing reduced levels of Huntingtin. Hum Mol Genet. 2001;10:2515\u201323.","journal-title":"Hum Mol Genet"},{"key":"1443_CR24","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.14336\/AD.2023.0423","volume":"14","author":"JM Van Raamsdonk","year":"2023","unstructured":"Van Raamsdonk JM, Al-Shekaili HH, Wagner L, Bredy TW, Chan L, Pearson J, et al. Huntingtin decreases susceptibility to a spontaneous seizure disorder in FVN\/B mice. Aging Dis. 2023;14:2249\u201366.","journal-title":"Aging Dis"},{"key":"1443_CR25","doi-asserted-by":"publisher","first-page":"5736","DOI":"10.1073\/pnas.1603871113","volume":"113","author":"AE Molero","year":"2016","unstructured":"Molero AE, Arteaga-Bracho EE, Chen CH, Gulinello M, Winchester ML, Pichamoorthy N, et al. Selective expression of mutant Huntingtin during development recapitulates characteristic features of huntington\u2019s disease. Proc Natl Acad Sci U S A. 2016;113:5736\u201341.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1443_CR26","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3389\/fneur.2013.00127","volume":"4","author":"L Moumn\u00e9","year":"2013","unstructured":"Moumn\u00e9 L, Betuing S, Caboche J. Multiple aspects of gene dysregulation in huntington\u2019s disease. Front Neurol. 2013;4:127.","journal-title":"Front Neurol"},{"key":"1443_CR27","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.3389\/fgene.2021.751033","volume":"12","author":"B Malla","year":"2021","unstructured":"Malla B, Guo X, Senger G, Chasapopoulou Z, Yildirim F. A systematic review of transcriptional dysregulation in huntington\u2019s disease studied by RNA sequencing. Front Genet. 2021;12:1898.","journal-title":"Front Genet"},{"key":"1443_CR28","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.nbd.2011.07.001","volume":"45","author":"T Seredenina","year":"2012","unstructured":"Seredenina T, Luthi-Carter R. What have we learned from gene expression profiles in huntington\u2019s disease? Neurobiol Dis. 2012;45:83\u201398.","journal-title":"Neurobiol Dis"},{"key":"1443_CR29","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1093\/hmg\/ddl013","volume":"15","author":"A Hodges","year":"2006","unstructured":"Hodges A, Strand AD, Aragaki AK, Kuhn A, Sengstag T, Hughes G, et al. Regional and cellular gene expression changes in human huntington\u2019s disease brain. Hum Mol Genet. 2006;15:965\u201377.","journal-title":"Hum Mol Genet"},{"key":"1443_CR30","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1093\/hmg\/9.9.1259","volume":"9","author":"R Luthi-Carter","year":"2000","unstructured":"Luthi-Carter R, Strand A, Peters NL, Solano SM, Hollingsworth ZR, Menon AS, et al. Decreased expression of striatal signaling genes in a mouse model of huntington\u2019s disease. Hum Mol Genet. 2000;9:1259\u201371.","journal-title":"Hum Mol Genet"},{"key":"1443_CR31","doi-asserted-by":"publisher","first-page":"7219","DOI":"10.1093\/nar\/gkq575","volume":"38","author":"E Mart\u00ed","year":"2010","unstructured":"Mart\u00ed E, Pantano L, Ba\u00f1ez-Coronel M, Llorens F, Mi\u00f1ones-Moyano E, Porta S, et al. A myriad of MiRNA variants in control and huntington\u2019s disease brain regions detected by massively parallel sequencing. Nucleic Acids Res. 2010;38:7219\u201335.","journal-title":"Nucleic Acids Res"},{"key":"1443_CR32","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.3390\/ijms21051854","volume":"21","author":"M Dabrowska","year":"2020","unstructured":"Dabrowska M, Ciolak A, Kozlowska E, Fiszer A, Olejniczak M. Generation of new isogenic models of huntington\u2019s disease using CRISPR-Cas9 technology. Int J Mol Sci. 2020;21:1854.","journal-title":"Int J Mol Sci"},{"key":"1443_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12915-023-01515-3","volume":"21","author":"P Joachimiak","year":"2023","unstructured":"Joachimiak P, Ciesio\u0142ka A, Koz\u0142owska E, \u015awito\u0144ski PM, Figura G, Cio\u0142ak A, et al. Allele-specific quantitation of ATXN3 and HTT transcripts in PolyQ disease models. BMC Biol. 2023;21:1\u201316.","journal-title":"BMC Biol"},{"key":"1443_CR34","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00018-020-03596-7","volume":"78","author":"A Ciesiolka","year":"2021","unstructured":"Ciesiolka A, Stroynowska-Czerwinska A, Joachimiak P, Ciolak A, Kozlowska E, Michalak M, et al. Artificial MiRNAs targeting CAG repeat expansion in ORFs cause rapid deadenylation and translation Inhibition of mutant transcripts. Cell Mol Life Sci. 2021;78:1577\u201396.","journal-title":"Cell Mol Life Sci"},{"key":"1443_CR35","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/978-1-4939-7825-0_27","volume":"1780","author":"M Fjodorova","year":"2018","unstructured":"Fjodorova M, Li M. Robust induction of DARPP32-Expressing GABAergic striatal neurons from human pluripotent stem cells. Methods Mol Biol. 2018;1780:585\u2013605.","journal-title":"Methods Mol Biol"},{"key":"1443_CR36","doi-asserted-by":"publisher","first-page":"6986","DOI":"10.1074\/jbc.RA118.007204","volume":"294","author":"RJ Harding","year":"2019","unstructured":"Harding RJ, Loppnau P, Ackloo S, Lemak A, Hutchinson A, Hunt B, et al. Design and characterization of mutant and wildtype Huntingtin proteins produced from a toolkit of scalable eukaryotic expression systems. J Biol Chem. 2019;294:6986\u20137001.","journal-title":"J Biol Chem"},{"key":"1443_CR37","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/pro.4218","volume":"31","author":"PD Thomas","year":"2022","unstructured":"Thomas PD, Ebert D, Muruganujan A, Mushayahama T, Albou LP, Mi H. PANTHER: making genome-scale phylogenetics accessible to all. Protein Sci. 2022;31:8\u201322.","journal-title":"Protein Sci"},{"key":"1443_CR38","doi-asserted-by":"publisher","first-page":"e0143563","DOI":"10.1371\/journal.pone.0143563","volume":"10","author":"A Labadorf","year":"2015","unstructured":"Labadorf A, Hoss AG, Lagomarsino V, Latourelle JC, Hadzi TC, Bregu J, et al. RNA sequence analysis of human huntington disease brain reveals an extensive increase in inflammatory and developmental gene expression. PLoS ONE. 2015;10:e0143563.","journal-title":"PLoS ONE"},{"key":"1443_CR39","doi-asserted-by":"publisher","first-page":"11850","DOI":"10.1074\/jbc.RA117.001211","volume":"293","author":"Y Pan","year":"2018","unstructured":"Pan Y, Zhu Y, Yang W, Tycksen E, Liu S, Palucki J, et al. The role of Twist1 in mutant huntingtin-induced transcriptional alterations and neurotoxicity. J Biol Chem. 2018;293:11850\u201366.","journal-title":"J Biol Chem"},{"key":"1443_CR40","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1007\/s12035-019-01836-x","volume":"57","author":"WP Jen","year":"2020","unstructured":"Jen WP, Chen HM, Lin YS, Chern Y, Lee YC. Twist1 plays an Anti-apoptotic role in mutant Huntingtin expression striatal progenitor cells. Mol Neurobiol. 2020;57:1688\u2013703.","journal-title":"Mol Neurobiol"},{"key":"1443_CR41","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s12017-012-8183-0","volume":"14","author":"M Sinha","year":"2012","unstructured":"Sinha M, Mukhopadhyay S, Bhattacharyya NP. Mechanism(s) of alteration of micro RNA expressions in huntington\u2019s disease and their possible contributions to the observed cellular and molecular dysfunctions in the disease. NeuroMolecular Med. 2012;14:221\u201343.","journal-title":"NeuroMolecular Med"},{"key":"1443_CR42","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12017-009-8063-4","volume":"11","author":"R Johnson","year":"2009","unstructured":"Johnson R, Buckley NJ. Gene dysregulation in huntington\u2019s disease: REST, MicroRNAs and beyond. Neuromolecular Med. 2009;11:183\u201399.","journal-title":"Neuromolecular Med"},{"key":"1443_CR43","doi-asserted-by":"publisher","first-page":"E264","DOI":"10.1212\/WNL.0000000000004844","volume":"90","author":"ER Reed","year":"2018","unstructured":"Reed ER, Latourelle JC, Bockholt JH, Bregu J, Smock J, Paulsen JS, et al. MicroRNAs in CSF as prodromal biomarkers for huntington disease in the PREDICT-HD study. Neurology. 2018;90:E264\u201372.","journal-title":"Neurology"},{"key":"1443_CR44","doi-asserted-by":"crossref","unstructured":"Petry S, Keraudren R, Nateghi B, Loiselle A, Pircs K, Jakobsson J et al. Widespread alterations in MicroRNA biogenesis in human huntington\u2019s disease putamen. Acta Neuropathol Commun. 2022;10.","DOI":"10.1186\/s40478-022-01407-7"},{"key":"1443_CR45","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.bbrc.2010.05.007","volume":"396","author":"M Sinha","year":"2010","unstructured":"Sinha M, Ghose J, Das E, Bhattarcharyya NP. Altered MicroRNAs in STHdh(Q111)\/Hdh(Q111) cells: miR-146a targets TBP. Biochem Biophys Res Commun. 2010;396:742\u20137.","journal-title":"Biochem Biophys Res Commun"},{"key":"1443_CR46","doi-asserted-by":"publisher","first-page":"16999","DOI":"10.3390\/ijms140816999","volume":"14","author":"E Kozlowska","year":"2013","unstructured":"Kozlowska E, Krzyzosiak WJ, Koscianska E. Regulation of Huntingtin gene expression by miRNA-137, -214, -148a, and their respective IsomiRs. Int J Mol Sci. 2013;14:16999\u20137016.","journal-title":"Int J Mol Sci"},{"key":"1443_CR47","doi-asserted-by":"crossref","unstructured":"Sinha M, Ghose J, Bhattarcharyya NP. Micro RNA\u2013\u2009214,-150,-146a and-125b target Huntingtin gene. RNA Biol. 2011;8.","DOI":"10.4161\/rna.8.6.16035"},{"key":"1443_CR48","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1093\/nar\/gkn920","volume":"37","author":"YB Lee","year":"2009","unstructured":"Lee YB, Bantounas I, Lee DY, Phylactou L, Caldwell MA, Uney JB. Twist-1 regulates the miR-199a\/214 cluster during development. Nucleic Acids Res. 2009;37:123\u20138.","journal-title":"Nucleic Acids Res"},{"key":"1443_CR49","doi-asserted-by":"publisher","first-page":"14341","DOI":"10.1523\/JNEUROSCI.2390-08.2008","volume":"28","author":"AN Packer","year":"2008","unstructured":"Packer AN, Xing Y, Harper SQ, Jones L, Davidson BL. The bifunctional MicroRNA miR-9\/miR-9* regulates REST and CoREST and is downregulated in huntington\u2019s disease. J Neurosci. 2008;28:14341\u20136.","journal-title":"J Neurosci"},{"key":"1443_CR50","doi-asserted-by":"crossref","unstructured":"Babion I, Jaspers A, van Splunter AP, van der Hoorn IAE, Wilting SM, Steenbergen RDM. miR-9-5p exerts a dual role in cervical Cancer and targets transcription factor TWIST1. Cells. 2019;9.","DOI":"10.3390\/cells9010065"},{"key":"1443_CR51","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.stem.2012.04.027","volume":"11","author":"The HD iPSC Consortium","year":"2012","unstructured":"The HD iPSC Consortium. Induced pluripotent stem cells from patients with huntington\u2019s disease show CAG-repeat-expansion-associated phenotypes. Cell Stem Cell. 2012;11:264\u201378.","journal-title":"Cell Stem Cell"},{"key":"1443_CR52","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3389\/fncel.2018.00528","volume":"12","author":"K \u015awito\u0144ska","year":"2019","unstructured":"\u015awito\u0144ska K, Szlachcic WJ, Handschuh L, Wojciechowski P, Marczak \u0141, Stelmaszczuk M, et al. Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling. Front Cell Neurosci. 2019;12:528.","journal-title":"Front Cell Neurosci"},{"key":"1443_CR53","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.stem.2012.04.026","volume":"11","author":"MC An","year":"2012","unstructured":"An MC, Zhang N, Scott G, Montoro D, Wittkop T, Mooney S, et al. Genetic correction of huntington\u2019s disease phenotypes in induced pluripotent stem cells. Cell Stem Cell. 2012;11:253\u201363.","journal-title":"Cell Stem Cell"},{"key":"1443_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-023-39552-9","volume":"14","author":"GM Ferlazzo","year":"2023","unstructured":"Ferlazzo GM, Gambetta AM, Amato S, Cannizzaro N, Angiolillo S, Arboit M, et al. Genome-wide screening in pluripotent cells identifies Mtf1 as a suppressor of mutant Huntingtin toxicity. Nat Commun. 2023;14:1\u201324.","journal-title":"Nat Commun"},{"key":"1443_CR55","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/hmg\/ddl467","volume":"16","author":"ANT Strehlow","year":"2007","unstructured":"Strehlow ANT, Li JZ, Myers RM. Wild-type Huntingtin participates in protein trafficking between the golgi and the extracellular space. Hum Mol Genet. 2007;16:391\u2013409.","journal-title":"Hum Mol Genet"},{"key":"1443_CR56","doi-asserted-by":"publisher","first-page":"104720","DOI":"10.1016\/j.ebiom.2023.104720","volume":"94","author":"V Tano","year":"2023","unstructured":"Tano V, Utami KH, Yusof NABM, B\u00e9gin J, Tan WWL, Pouladi MA, et al. Widespread dysregulation of mRNA splicing implicates RNA processing in the development and progression of huntington\u2019s disease. eBioMedicine. 2023;94:104720.","journal-title":"eBioMedicine"},{"key":"1443_CR57","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.stemcr.2015.11.005","volume":"5","author":"KL Ring","year":"2015","unstructured":"Ring KL, An MC, Zhang N, O\u2019Brien RN, Ramos EM, Gao F, et al. Genomic analysis reveals disruption of striatal neuronal development and therapeutic targets in human huntington\u2019s disease neural stem cells. Stem Cell Rep. 2015;5:1023\u201338.","journal-title":"Stem Cell Rep"},{"key":"1443_CR58","doi-asserted-by":"publisher","first-page":"2494","DOI":"10.1016\/j.celrep.2019.02.008","volume":"26","author":"J Ooi","year":"2019","unstructured":"Ooi J, Langley SR, Xu X, Utami KH, Sim B, Huang Y, et al. Unbiased profiling of isogenic huntington disease hPSC-Derived CNS and peripheral cells reveals strong Cell-Type specificity of CAG length effects. Cell Rep. 2019;26:2494\u2013e25087.","journal-title":"Cell Rep"},{"key":"1443_CR59","doi-asserted-by":"crossref","unstructured":"Sorek M, Oweis W, Nissim-Rafinia M, Maman M, Simon S, Hession CC et al. Pluripotent stem cell-derived models of neurological diseases reveal early transcriptional heterogeneity. Genome Biol. 2021;22.","DOI":"10.1186\/s13059-021-02301-6"},{"key":"1443_CR60","doi-asserted-by":"crossref","unstructured":"Tshilenge KT, Aguirre CG, Bons J, Gerencser AA, Basisty N, Song S et al. Proteomic analysis of huntington\u2019s disease medium spiny neurons identifies alterations in lipid droplets. Mol Cell Proteom. 2023;22.","DOI":"10.1016\/j.mcpro.2023.100534"},{"key":"1443_CR61","doi-asserted-by":"crossref","unstructured":"Wu GH, Smith-Geater C, Galaz-Montoya JG, Gu Y, Gupte SR, Aviner R et al. CryoET reveals organelle phenotypes in huntington disease patient iPSC-derived and mouse primary neurons. Nat Commun. 2023;14.","DOI":"10.1038\/s41467-023-36096-w"},{"key":"1443_CR62","doi-asserted-by":"publisher","first-page":"105732","DOI":"10.1016\/j.isci.2022.105732","volume":"26","author":"AM Reyes-Ortiz","year":"2023","unstructured":"Reyes-Ortiz AM, Abud EM, Burns MS, Wu J, Hernandez SJ, McClure N, et al. Single-nuclei transcriptome analysis of huntington disease iPSC and mouse astrocytes implicates maturation and functional deficits. iScience. 2023;26:105732.","journal-title":"iScience"},{"key":"1443_CR63","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.stemcr.2017.01.022","volume":"8","author":"X Xu","year":"2017","unstructured":"Xu X, Tay Y, Sim B, Yoon S-II, Huang Y, Ooi J, et al. Reversal of phenotypic abnormalities by CRISPR\/Cas9-Mediated gene correction in huntington disease Patient-Derived induced pluripotent stem cells. Stem Cell Rep. 2017;8:619\u201333.","journal-title":"Stem Cell Rep"},{"key":"1443_CR64","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00438-013-0734-z","volume":"288","author":"S Arora","year":"2013","unstructured":"Arora S, Rana R, Chhabra A, Jaiswal A, Rani V. miRNA\u2013transcription factor interactions: a combinatorial regulation of gene expression. Mol Genet Genomics 2013 2883. 2013;288:77\u201387.","journal-title":"Mol Genet Genomics 2013 2883"},{"key":"1443_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2164-8-396","volume":"8","author":"Y Zhou","year":"2007","unstructured":"Zhou Y, Ferguson J, Chang JT, Kluger Y. Inter- and intra-combinatorial regulation by transcription factors and MicroRNAs. BMC Genomics. 2007;8:1\u201310.","journal-title":"BMC Genomics"},{"key":"1443_CR66","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.cell.2005.10.030","volume":"123","author":"W Zhai","year":"2005","unstructured":"Zhai W, Jeong H, Cui L, Krainc D, Tjian R. In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets. Cell. 2005;123:1241\u201353.","journal-title":"Cell"},{"key":"1443_CR67","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3233\/JHD-170272","volume":"7","author":"RAG De Souza","year":"2018","unstructured":"De Souza RAG, Kosior N, Thomson SB, Mathelier A, Zhang AW, Be\u010danovi\u0107 K, et al. Computational analysis of transcriptional regulation sites at the HTT gene locus. J Huntingtons Dis. 2018;7:223\u201337.","journal-title":"J Huntingtons Dis"},{"key":"1443_CR68","doi-asserted-by":"publisher","first-page":"10720","DOI":"10.1523\/JNEUROSCI.2126-08.2008","volume":"28","author":"CL Benn","year":"2008","unstructured":"Benn CL, Sun T, Sadri-Vakili G, McFarland KN, DiRocco DP, Yohrling GJ, et al. Huntingtin modulates transcription, occupies gene promoters in vivo, and binds directly to DNA in a Polyglutamine-Dependent manner. J Neurosci. 2008;28:10720\u201333.","journal-title":"J Neurosci"},{"key":"1443_CR69","doi-asserted-by":"publisher","first-page":"7466","DOI":"10.1074\/jbc.M103946200","volume":"277","author":"KB Kegel","year":"2002","unstructured":"Kegel KB, Meloni AR, Yi Y, Kim YJ, Doyle E, Cuiffo BG, et al. Huntingtin is present in the nucleus, interacts with the transcriptional corepressor C-terminal binding protein, and represses transcription. J Biol Chem. 2002;277:7466\u201376.","journal-title":"J Biol Chem"},{"key":"1443_CR70","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1126\/science.1059581","volume":"293","author":"C Zuccato","year":"2001","unstructured":"Zuccato C, Ciammola A, Rigamonti D, Leavitt BR, Goffredo D, Conti L, et al. Loss of huntingtin-mediated BDNF gene transcription in huntington\u2019s disease. Science. 2001;293:493\u20138.","journal-title":"Science"},{"key":"1443_CR71","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S1566-2772(03)00059-8","volume":"3","author":"R Luthi-Carter","year":"2003","unstructured":"Luthi-Carter R, Cha JHJ. Mechanisms of transcriptional dysregulation in huntington\u2019s disease. Clin Neurosci Res. 2003;3:165\u201377.","journal-title":"Clin Neurosci Res"},{"key":"1443_CR72","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/cr.2011.144","volume":"22","author":"Q Qin","year":"2012","unstructured":"Qin Q, Xu Y, He T, Qin C, Xu J. Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms. Cell Res. 2012;22:90\u2013106.","journal-title":"Cell Res"},{"key":"1443_CR73","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.nbd.2007.11.001","volume":"29","author":"R Johnson","year":"2008","unstructured":"Johnson R, Zuccato C, Belyaev ND, Guest DJ, Cattaneo E, Buckley NJ. A microRNA-based gene dysregulation pathway in huntington\u2019s disease. Neurobiol Dis. 2008;29:438\u201345.","journal-title":"Neurobiol Dis"},{"key":"1443_CR74","doi-asserted-by":"publisher","first-page":"106914","DOI":"10.1016\/j.nbd.2025.106914","volume":"210","author":"JT Stocksdale","year":"2025","unstructured":"Stocksdale JT, Leventhal MJ, Lam S, Xu YX, Wang YO, Wang KQ, et al. Intersecting impact of CAG repeat and Huntingtin knockout in stem cell-derived cortical neurons. Neurobiol Dis. 2025;210:106914.","journal-title":"Neurobiol Dis"},{"key":"1443_CR75","doi-asserted-by":"crossref","unstructured":"Lou\u00e7\u00e3 M, El Akrouti D, Lemesle A, Louessard M, Dufour N, Baroin C et al. Huntingtin Lowering impairs the maturation and synchronized synaptic activity of human cortical neuronal networks derived from induced pluripotent stem cells. Neurobiol Dis. 2024;200.","DOI":"10.1016\/j.nbd.2024.106630"},{"key":"1443_CR76","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/hmg\/ddaa283","volume":"30","author":"R Jung","year":"2021","unstructured":"Jung R, Lee Y, Barker D, Correia K, Shin B, Loupe J, et al. Mutations causing Lopes-Maciel-Rodan syndrome are Huntingtin hypomorphs. Hum Mol Genet. 2021;30:135\u201348.","journal-title":"Hum Mol Genet"},{"key":"1443_CR77","doi-asserted-by":"crossref","unstructured":"Rodan LH, Cohen J, Fatemi A, Gillis T, Lucente D, Gusella J et al. A novel neurodevelopmental disorder associated with compound heterozygous variants in the Huntingtin gene. 2016;24:1826\u20137.","DOI":"10.1038\/ejhg.2016.74"},{"key":"1443_CR78","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1136\/jmedgenet-2015-103568","volume":"53","author":"F Lopes","year":"2016","unstructured":"Lopes F, Barbosa M, Ameur A, Soares G, De S\u00e1 J, Dias AI, et al. Identification of novel genetic causes of Rett syndrome-like phenotypes. J Med Genet. 2016;53:190\u20139.","journal-title":"J Med Genet"},{"key":"1443_CR79","doi-asserted-by":"crossref","unstructured":"Becanovic K, N\u00f8rrem\u00f8lle A, Neal SJ, Kay C, Collins JA, Arenillas D et al. A SNP in the HTT promoter alters NF-\u03baB binding and is a bidirectional genetic modifier of Huntington disease. Nat Neurosci 2015 186. 2015;18:807\u201316.","DOI":"10.1038\/nn.4014"},{"key":"1443_CR80","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1471-2202-7-80","volume":"7","author":"JM Van Raamsdonk","year":"2006","unstructured":"Van Raamsdonk JM, Pearson J, Murphy Z, Hayden MR, Leavitt BR. Wild-type Huntingtin ameliorates striatal neuronal atrophy but does not prevent other abnormalities in the YAC128 mouse model of huntington disease. BMC Neurosci. 2006;7:80.","journal-title":"BMC Neurosci"},{"key":"1443_CR81","doi-asserted-by":"publisher","first-page":"1252521","DOI":"10.3389\/fcell.2023.1252521","volume":"11","author":"TL Laundos","year":"2023","unstructured":"Laundos TL, Li S, Cheang E, De Santis R, Piccolo FM, Brivanlou AH. Huntingtin CAG-expansion mutation results in a dominant negative effect. Front Cell Dev Biol. 2023;11:1252521.","journal-title":"Front Cell Dev Biol"},{"key":"1443_CR82","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1002\/pro.3667","volume":"28","author":"LT Bergendahl","year":"2019","unstructured":"Bergendahl LT, Gerasimavicius L, Miles J, Macdonald L, Wells JN, Welburn JPI, et al. The role of protein complexes in human genetic disease. Protein Sci. 2019;28:1400\u201311.","journal-title":"Protein Sci"},{"key":"1443_CR83","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/cge.13107","volume":"93","author":"RA Veitia","year":"2018","unstructured":"Veitia RA, Caburet S, Birchler JA. Mechanisms of Mendelian dominance. Clin Genet. 2018;93:419\u201328.","journal-title":"Clin Genet"},{"key":"1443_CR84","doi-asserted-by":"crossref","unstructured":"Bragg RM, Mathews EW, Grindeland A, Cantle JP, Howland D, Vogt T et al. Global Huntingtin knockout in adult mice leads to fatal neurodegeneration that spares the pancreas. Life Sci Alliance. 2024;7.","DOI":"10.1101\/2024.01.11.575238"}],"container-title":["Cell &amp; Bioscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-025-01443-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13578-025-01443-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-025-01443-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T04:12:46Z","timestamp":1757218366000},"score":1,"resource":{"primary":{"URL":"https:\/\/cellandbioscience.biomedcentral.com\/articles\/10.1186\/s13578-025-01443-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":84,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1443"],"URL":"https:\/\/doi.org\/10.1186\/s13578-025-01443-5","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.05.20.594947","asserted-by":"object"}]},"ISSN":["2045-3701"],"issn-type":[{"value":"2045-3701","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"assertion":[{"value":"3 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Figure 2 sizing is adjusted to fit full page width.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"100"}}